GENinCode Plc (LON:GENI – Get Free Report)’s share price traded down 10.8% on Wednesday . The company traded as low as GBX 4.15 ($0.05) and last traded at GBX 4.15 ($0.05). 202,541 shares changed hands during mid-day trading, a decline of 5% from the average session volume of 214,060 shares. The stock had previously closed at GBX 4.65 ($0.06).
GENinCode Price Performance
The company has a debt-to-equity ratio of 9.27, a current ratio of 2.60 and a quick ratio of 15.89. The business’s fifty day moving average price is GBX 6.02 and its 200-day moving average price is GBX 6.87. The stock has a market capitalization of £7.08 million, a price-to-earnings ratio of -81.56 and a beta of 0.66.
About GENinCode
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Read More
- Five stocks we like better than GENinCode
- Best Aerospace Stocks Investing
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- The Role Economic Reports Play in a Successful Investment Strategy
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- How to Buy Cheap Stocks Step by Step
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
